Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study

por Scheerer, Markus F, Rist, Roland, Proske, Orm, Meng, Annika, Kostev, Karel
Publicado 2016

Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study

por Kostev, Karel, Pscherer, Stefan, Rist, Roland, Busch, Stefan, Scheerer, Markus F.
Publicado 2017